NCT03083548

Brief Summary

The Nor-Hand study is a hospital-based observational study including 300 patients with evidence of hand OA by ultrasound and/or clinical examination. The baseline examination (2016-17) consists of functional tests and joint assessment of the hands, medical assessment, pain sensitization tests, ultrasound (hands, acromioclavicular joint, hips, knees and feet), computer tomography (CT) and Magnetic Resonance Imaging (MRI) of the dominant hand, conventional radiographs of the hands and feet, fluorescence optical imaging of the hands, collection of blood and urine samples as well as self-reported demographic factors and OA-related questionnaires. Two follow-up examinations are planned after 3 (2019-20) and 8 years (2024-25), respectively. Cross-sectional analyses will be used to investigate agreements and associations between different relevant measures at the baseline examination, whereas the longitudinal data will be used for evaluation of predictors for clinical outcomes and disease progression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 20, 2017

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

September 19, 2025

Status Verified

September 1, 2025

Enrollment Period

5.1 years

First QC Date

March 8, 2017

Last Update Submit

September 18, 2025

Conditions

Outcome Measures

Primary Outcomes (73)

  • Demographic factors

    Self-reported relationship status, education, employment, hand tasks in work/previous work, birth place

    Baseline

  • Demographic factors

    Self-reported relationship status, social network, education, employment

    3 year follow-up

  • Life style factors

    Self-reported physical activity, smoking, use of alcohol (AUDIT-C)

    Baseline

  • Life style factors

    Self-reported physical activity, smoking, use of alcohol (AUDIT-C)

    3 year follow-up

  • Clinical disease variables

    Self-reported year diagnosed with OA, number of years with OA symptoms, OA in family, previous injuries of hand/foot, use of medications, previous steroid injections, use of hand orthoses, use of customized tools, previous surgeries, use of alternative therapies, use of supplements, use of nature cures, use of self-help techniques

    Baseline

  • Clinical disease variables

    Previous injuries of hand/foot, use of medications, previous steroid injections, use of hand orthoses, use of customized tools, previous surgeries, use of alternative therapies, use of supplements, use of nature cures, use of self-help techniques

    3 year follow-up

  • EuroQol 5 dimensions

    Self-reported mobility, self-care, usual activity, pain/discomfort, anxiety/depression

    Baseline

  • EuroQol 5 dimensions

    Self-reported mobility, self-care, usual activity, pain/discomfort, anxiety/depression

    3 year follow-up

  • Sleep disturbances

    Self-reported sleep disturbances

    Baseline

  • Sleep disturbances

    Self-reported sleep disturbances

    3 year follow-up

  • Michigan Hand Outcomes Questionnaire (MHOQ)

    Aesthetic damage subscale

    Baseline

  • Michigan Hand Outcomes Questionnaire (MHOQ)

    All subscales

    3 year follow-up

  • Localization of joint pain (homonculus)

    Self-reported pain during the last 24 hours and previous 6 weeks

    Baseline

  • Localization of joint pain (homonculus)

    Self-reported pain during the last 24 hours and previous 6 weeks

    3 year follow-up

  • Self-reported joint pain, hand pain, feet pain, fatigue, disease activity

    Numeric Rating Scale (0-10)

    Baseline

  • Self-reported joint pain, hand pain, feet pain, fatigue, disease activity

    Numeric Rating Scale (0-10)

    3 year follow-up

  • Australian/Canadian hand index (AUSCAN)

    Self-reported hand pain, stiffness and physical function

    Baseline

  • Australian/Canadian hand index (AUSCAN)

    Self-reported hand pain, stiffness and physical function

    3 year follow-up

  • Western Ontario and McMaster Universities Arthrtis Index (WOMAC)

    Self-reported knee/hip pain, stiffness and physical function

    Baseline

  • Western Ontario and McMaster Universities Arthrtis Index (WOMAC)

    Self-reported knee/hip pain, stiffness and physical function

    3 year follow-up

  • Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)

    Modified version to assess constant and intermittent pain in patients with hand OA (self-reported)

    Baseline

  • McGill Questionnaire

    Modified version to assess hand OA pain characteristics (self-reported)

    Baseline

  • PainDetect

    Modified version to assess neuropathic hand pain (self-reported)

    Baseline

  • PainDetect

    Modified version to assess neuropathic hand pain (self-reported)

    3 year follow-up

  • Brief Approach/Avoidance Coping Questionnaire (BACQ)

    Self-reported approach-oriented and avoidance oriented coping

    Baseline

  • Pain catastrophizing scale

    Self-reported magnification, rumination, helplessness

    Baseline

  • Pain catastrophizing scale

    Self-reported magnification, rumination, helplessness

    3 year follow-up

  • Self-efficacy scales

    Self-reported ability influence pain and symptoms

    Baseline

  • Self-efficacy scales

    Self-reported ability influence pain and symptoms

    3 year follow-up

  • Foot Function Index

    Self-reported pain in feet, disability, activity restrictions

    Baseline

  • Foot Function Index

    Self-reported pain in feet, disability, activity restrictions

    3 year follow-up

  • Hormonal factors in women

    Menopause

    Baseline

  • Hormonal factors in women

    Menarche, menopause, gynecological operations, hormone treatment, pregnancies, breastfeeding

    3 year follow-up

  • Use of shoewear

    The use of shoes with varying type of forefoot and heels

    3 year follow-up

  • Global health assessment

    The evaluation of the global health on Visual analogue scale (VAS)

    3 year follow-up

  • Pain Sensitivity Questionnaire

    Pain in different daily-life situations, normally leading to no or little pain

    3 year follow-up

  • Fibromyalgia symptoms

    ACR criteria for fibromyalgia

    3 year follow-up

  • Short form 12 Energy

    One question from Short form 12 about poor energy

    3 year follow-up

  • Brief Illness Perception Questionnaire

    Illness perception related to their hand OA disease and symptoms

    3 year follow-up

  • Height

    Examination of height in standing position (performed by medical student)

    Baseline

  • Height

    Examination of height in standing position (performed by medical student)

    3 year follow-up

  • Weight

    Examination of weight in light-weighted clothes (performed by medical student)

    Baseline

  • Weight

    Examination of weight in light-weighted clothes (performed by medical student)

    3 year follow-up

  • Hip/waist circumference

    Examination of hip and waist circumference (performed by medical student)

    Baseline

  • Hip/waist circumference

    Examination of hip and waist circumference (performed by medical student)

    3 year follow-up

  • Blood pressure

    Examination of blood pressure after rest (performed by medical student)

    Baseline

  • Blood pressure

    Examination of blood pressure after rest (performed by medical student)

    3 year follow-up

  • Heart rate

    Examination heart rate after rest (performed by medical student)

    Baseline

  • Heart rate

    Examination heart rate after rest (performed by medical student)

    3 year follow-up

  • Comorbidity questionnaires and medications

    Self-reported comorbidities and medications

    Baseline

  • Comorbidity questionnaires and medications

    Self-reported comorbidities and medications

    3 year follow-up

  • Hair sample

    Small hair sample is collected from the back of the patients´ head for quantification of cortisol

    Baseline

  • Joint assessment (examination by rheumatologist)

    Bony enlargement, tenderness (Doyle index in hand) and soft tissue swelling in hands and feet, and assessment of the ACR criteria of hand, knee and hip

    Baseline

  • Joint assessment (examination by rheumatologist)

    Bony enlargement, tenderness (Doyle index in hand) and soft tissue swelling in hands and feet, and assessment of the ACR criteria of hand, knee and hip

    3 year follow-up

  • Grip strength

    Bilateral measurement of grip strength using Jamar dynamometer

    Baseline, follow-up

  • Grip strength

    Bilateral measurement of grip strength using Jamar dynamometer

    3 year follow-up

  • Moberg Pick-Up test

    Bilateral measurement of fine motor acitivities (time to pick up small elements and put in the box)

    Baseline

  • Moberg Pick-Up test

    Bilateral measurement of fine motor acitivities (time to pick up small elements and put in the box)

    3 year follow-up

  • Chair Stand test

    Number of chair stands during 30 sec

    3 year follow-up

  • 40 m walking test

    Time in sec for 40 m walking

    3 year follow-up

  • Pain sensitization tests

    Temporal summation, pressure pain threshold (painful finger joint, non-painful finger joint, trapezius muscle, left distal radioulnar joint and tibialis anterior muscle), conditioned pain modulation, light touch

    Baseline

  • Pain sensitization tests

    Temporal summation, pressure pain threshold (painful finger joint, non-painful finger joint, trapezius muscle, left distal radioulnar joint and tibialis anterior muscle), conditioned pain modulation, light touch

    3 year follow-up

  • Ultrasound examination

    Osteophytes, grey-scale synovitis and power doppler activity in hands, AC joint, hips, knees and feet

    Baseline

  • Ultrasound examination

    Osteophytes, grey-scale synovitis and power doppler activity in hands, AC joint, hips, knees and feet

    3 year follow-up

  • Fluorescence Optical Imaging

    Examination of altered microcirculation in the hands

    Baseline

  • Fluorescence Optical Imaging

    Examination of altered microcirculation in the hands

    3 year follow-up

  • Conventional radiographs

    Hands (frontal), feet (frontal, oblique and side images)

    Baseline

  • Conventional radiographs

    Hands (frontal), feet (frontal, oblique and side images)

    3 year follow-up

  • MRI

    MRI of dominant hand

    Baseline

  • MRI

    MRI of dominant hand

    3 year follow-up

  • CT

    CT of dominant hand

    Baseline

  • Biobank

    Collection of whole blood, serum, plasma and urine

    Baseline

  • Biobank

    Collection of whole blood, serum, plasma and urine

    3 year follow-up

Study Arms (1)

Hand osteoarthritis

Men and women (40-70 years) with a diagnosis of hand OA based on clinical or ultrasound examination are included. Patients with systemic inflammatory joint diseases, psoriasis and hemochromatosis are excluded.

Diagnostic Test: ImagingDiagnostic Test: Physical examinationsDiagnostic Test: Questionnnaires

Interventions

ImagingDIAGNOSTIC_TEST

Conventional radiographs (hands/feet), CT of dominant hand, MRI of dominant hand, ultrasound (hands/shoulder/feet/hips/knees), fluorescence optical imaging of hands

Hand osteoarthritis
Physical examinationsDIAGNOSTIC_TEST

Joint assessment of hands and feet, pain sensitization test and functional tests

Hand osteoarthritis
QuestionnnairesDIAGNOSTIC_TEST

Self-reported demographic factors, clinical variables and OA history and symptoms

Hand osteoarthritis

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of men and women between the ages of 40-70 years. Their diagnosis of hand OA has been proven either by ultrasound and/or clinical examination performed by a rheumatologist at the Rheumatology Outpatient clinic at Diakonhjemmet Hospital. In addition, all patients must be able to sign and understand an informed consent form.

You may qualify if:

  • Age between 40-70 years at screening
  • Proven hand OA by clinical examination and/or ultrasound
  • Clinical examination criteria: Heberden/Bouchards nodes and/or bony enlargement, squaring and/or deformity of the thumb base and no clinical signs of inflammatory arthritis (e.g. soft tissue swelling of two or less metacarpophalangeal (MCP) joints, and no soft tissue swelling of the wrist).
  • Ultrasound criteria: Osteophytes in the interphalangeal joints and/or the thumb base, and no signs of inflammatory arthritis (e.g. synovitis with power Doppler activity in two or less MCP joints and no synovitis with power Doppler activity in the wrist).
  • Capable of understanding and signing an informed consent form
  • Provided a written informed consent to participate in the study

You may not qualify if:

  • Diagnosis of inflammatory arthritic disease, e.g. seropositive or seronegative rheumatoid arthritis, psoriatic arthritis, reactive arthritis, spondyloarthritis or arthritis related to connective tissue disorders
  • Diagnosis of psoriasis
  • Erythrocyte sedimentation rate (ESR) \> 40 mm/hour and/or C-reactive protein (CRP) \>20 mg/L, without a known ongoing infection
  • Anti Cyclic Citrullinated Protein (anti-CCP) and/or rheumatoid factor positivity
  • Ferritin \>200 microgram/L for women and \>300 microgram/L for men and s-iron/s-total iron binding capacity (TIBC) above 50%
  • Major co-morbidities (e.g. severe malignancies, severe diabetes mellitus, severe infections, uncontrollable hypertension, severe cardiovascular disease or severe respiratory disease)
  • Mental or psychiatric disorders, alcohol or drug abuse, language difficulties or other factors that make compliance to the study protocol difficult.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diakonhjemmet Hospital

Oslo, Norway

Location

Related Publications (4)

  • Fjellstad CM, Mathiessen A, Slatkowsky-Christensen B, Kvien TK, Hammer HB, Haugen IK. Associations Between Ultrasound-Detected Synovitis, Pain, and Function in Interphalangeal and Thumb Base Osteoarthritis: Data From the Nor-Hand Cohort. Arthritis Care Res (Hoboken). 2020 Nov;72(11):1530-1535. doi: 10.1002/acr.24047.

  • Gloersen M, Steen Pettersen P, Kvien TK, Haugen IK. Validation of the Intermittent and Constant Osteoarthritis Pain Questionnaire in Patients with Hand Osteoarthritis: Results from the Nor-Hand Study. J Rheumatol. 2019 Jun;46(6):645-651. doi: 10.3899/jrheum.180835. Epub 2019 Mar 15.

  • Steen Pettersen P, Neogi T, Magnusson K, Berner Hammer H, Uhlig T, Kvien TK, Haugen IK. Peripheral and Central Sensitization of Pain in Individuals With Hand Osteoarthritis and Associations With Self-Reported Pain Severity. Arthritis Rheumatol. 2019 Jul;71(7):1070-1077. doi: 10.1002/art.40850. Epub 2019 May 14.

  • Gloersen M, Mulrooney E, Mathiessen A, Hammer HB, Slatkowsky-Christensen B, Faraj K, Isaksen T, Neogi T, Kvien TK, Magnusson K, Haugen IK. A hospital-based observational cohort study exploring pain and biomarkers in patients with hand osteoarthritis in Norway: The Nor-Hand protocol. BMJ Open. 2017 Sep 24;7(9):e016938. doi: 10.1136/bmjopen-2017-016938.

Biospecimen

Retention: SAMPLES WITH DNA

Serum, urine, plasma and whole-blood

MeSH Terms

Conditions

OsteoarthritisPainInflammation

Interventions

Diagnostic ImagingPhysical Examination

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Ida K Haugen, MD, PhD

    Diakonhjemmet Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

March 8, 2017

First Posted

March 20, 2017

Study Start

April 1, 2016

Primary Completion

May 1, 2021

Study Completion

May 1, 2021

Last Updated

September 19, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations